Personalis, Inc. Increase (Decrease) in Accounts Payable
Personalis, Inc. (PSNL) reported Increase (Decrease) in Accounts Payable of $3.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-04
- Personalis, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $4.63M, a 170.96% increase year-over-year.
- Personalis, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$809.00K, a 140.19% decline year-over-year.
- Personalis, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $1.82M.
- Personalis, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$990.00K, a 202.48% decline year-over-year.
- Personalis, Inc. increase (decrease) in accounts payable for fiscal 2025 was $4.55M.
- Personalis, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$8.92M, a 272.34% decline from fiscal 2023.
- Personalis, Inc. increase (decrease) in accounts payable for fiscal 2023 was $5.18M, a 67.63% increase from fiscal 2022.
- Personalis, Inc. increase (decrease) in accounts payable for fiscal 2022 was $3.09M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $3.82M 10-Q · filed 2026-08-04 | $5.64M derived: sum of 3 quarters · filed 2026-08-04 | $4.65M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$809.00K 10-Q · filed 2026-05-07 | $1.01M derived: sum of 2 quarters · filed 2026-05-07 | $20.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.73M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $829.00K derived: sum of 2 quarters · filed 2026-02-26 | $2.54M derived: sum of 3 quarters · filed 2026-08-04 | $4.55M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$990.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $718.00K derived: sum of 2 quarters · filed 2026-08-04 | $2.73M 10-Q · filed 2025-11-04 | -$2.06M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $3.72M 10-Q · filed 2026-08-04 | -$1.07M derived: sum of 3 quarters · filed 2026-08-04 | -$102.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.01M 10-Q · filed 2026-05-07 | -$2.78M derived: sum of 2 quarters · filed 2026-05-07 | -$1.81M derived: sum of 3 quarters · filed 2026-05-07 | -$1.27M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.82M derived: sum of 2 quarters · filed 2026-02-26 | -$3.29M derived: sum of 3 quarters · filed 2026-02-26 | -$8.92M 10-K · filed 2026-02-26 |
| 2024-09-30 | $966.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.50M derived: sum of 2 quarters · filed 2025-11-04 | -$4.13M 10-Q · filed 2025-11-04 | $1.79M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $536.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$5.10M 10-Q · filed 2025-08-05 | $826.00K derived: sum of 3 quarters · filed 2025-08-05 | $1.43M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$5.64M 10-Q · filed 2025-05-06 | $290.00K derived: sum of 2 quarters · filed 2025-05-06 | $894.00K derived: sum of 3 quarters · filed 2025-05-06 | $948.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $5.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $6.53M derived: sum of 2 quarters · filed 2025-02-27 | $6.58M derived: sum of 3 quarters · filed 2025-02-27 | $5.18M 10-K · filed 2025-02-27 |
| 2023-09-30 | $604.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $658.00K derived: sum of 2 quarters · filed 2024-11-06 | -$749.00K 10-Q · filed 2024-11-06 | $3.41M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$1.35M 10-Q · filed 2024-08-07 | $2.81M derived: sum of 3 quarters · filed 2024-08-07 | $1.66M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$1.41M 10-Q · filed 2024-05-08 | $2.75M derived: sum of 2 quarters · filed 2024-05-08 | $1.60M derived: sum of 3 quarters · filed 2024-05-08 | $550.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.01M derived: sum of 2 quarters · filed 2024-02-28 | $1.96M derived: sum of 3 quarters · filed 2024-02-28 | $3.09M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$2.21M derived: sum of 2 quarters · filed 2023-11-07 | -$1.07M 10-Q · filed 2023-11-07 | $1.00M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $80.00K 10-Q · filed 2023-08-08 | $2.15M derived: sum of 3 quarters · filed 2024-02-28 | -$1.30M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $1.13M 10-Q · filed 2023-05-03 | $3.21M derived: sum of 2 quarters · filed 2024-02-28 | -$250.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.85M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$1.38M derived: sum of 2 quarters · filed 2024-02-28 | $718.00K derived: sum of 3 quarters · filed 2024-02-28 | -$1.46M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$3.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$1.35M derived: sum of 2 quarters · filed 2022-11-02 | -$3.53M 10-Q · filed 2022-11-02 | -$1.15M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$75.00K 10-Q · filed 2022-08-03 | $2.30M derived: sum of 3 quarters · filed 2023-02-23 | $1.02M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$2.17M 10-Q · filed 2022-05-04 | $204.00K derived: sum of 2 quarters · filed 2023-02-23 | -$1.08M derived: sum of 3 quarters · filed 2023-02-23 | -$3.81M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.10M derived: sum of 2 quarters · filed 2023-02-23 | -$1.63M derived: sum of 3 quarters · filed 2023-02-23 | $751.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | -$1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$4.01M derived: sum of 2 quarters · filed 2021-11-04 | -$1.63M 10-Q · filed 2021-11-04 | -$704.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$348.00K 10-Q · filed 2021-08-04 | $576.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.21M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $2.38M 10-Q · filed 2021-05-05 | $3.31M derived: sum of 2 quarters · filed 2022-02-24 | $3.95M derived: sum of 3 quarters · filed 2022-02-24 | $4.60M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $924.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.56M derived: sum of 2 quarters · filed 2022-02-24 | $2.22M derived: sum of 3 quarters · filed 2022-02-24 | $1.40M 10-K · filed 2022-02-24 |
| 2019-09-30 | $637.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.29M derived: sum of 2 quarters · filed 2020-11-05 | $474.00K 10-Q · filed 2020-11-05 | $1.86M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $657.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$163.00K 10-Q · filed 2020-08-06 | $1.23M derived: sum of 3 quarters · filed 2021-02-25 | $1.37M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$820.00K 10-Q · filed 2020-05-07 | $571.00K derived: sum of 2 quarters · filed 2021-02-25 | $710.00K derived: sum of 3 quarters · filed 2021-02-25 | |
| 2018-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.53M derived: sum of 2 quarters · filed 2021-02-25 | $2.16M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $773.00K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $634.00K 10-Q · filed 2019-08-13 | |||
| 2017-12-31 | $2.63M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |